Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Fixed Capital/Sales

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDOCO REMEDIES Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.110.880.800.780.93

What is the latest Fixed Capital/Sales ratio of INDOCO REMEDIES ?

The latest Fixed Capital/Sales ratio of INDOCO REMEDIES is 1.11 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.11
Mar20240.88
Mar20230.80
Mar20220.78
Mar20210.93

How is Fixed Capital/Sales of INDOCO REMEDIES Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.11
26.14
Mar2024 0.88
10.00
Mar2023 0.8
2.56
Mar2022 0.78
-16.13
Mar2021 0.93 -

Other Financial Ratios of INDOCO REMEDIES


Compare Fixed Capital/Sales ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,875.5 Cr -0.9% -5.2% -22.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.4% 2.6% NA Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr -4.5% 0.7% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 5% 4.1% 37.2% Stock Analytics
CIPLA ₹108,978.0 Cr -0.5% -3.4% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 1.2% 10.2% 4.8% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-0.9%

-5.2%

-22.5%

SENSEX

-1%

-0.1%

7.9%


You may also like the below Video Courses